News headlines about Cigna Corporation (NYSE:CI) have trended somewhat positive on Sunday, Accern reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cigna Corporation earned a news sentiment score of 0.07 on Accern’s scale. Accern also assigned media stories about the health services provider an impact score of 74 out of 100, indicating that recent media coverage is likely to have an effect on the stock’s share price in the near future.
These are some of the media stories that may have effected Accern’s scoring:
- Inc. Sells 55 Shares of Chevron Corporation (CVX) (eslforkids.net)
- Founders Capital Management LLC Lowers Position in JP Morgan Chase & Co (JPM) (healthcaremenu.net)
- Illinois consumers to get peek at Obamacare rate changes, but uncertainty remains (chicagotribune.com)
- Top Ranked Growth Stocks to Buy for July 28th (zacks.com)
- Hundreds of U.S. counties at risk for no Obamacare insurer in 2018 (reuters.com)
A number of research firms recently weighed in on CI. Deutsche Bank AG began coverage on shares of Cigna Corporation in a research note on Wednesday, April 5th. They set a “buy” rating and a $172.00 price target for the company. Zacks Investment Research downgraded shares of Cigna Corporation from a “hold” rating to a “sell” rating in a research note on Wednesday, April 5th. Credit Suisse Group began coverage on shares of Cigna Corporation in a research note on Monday, June 12th. They set an “outperform” rating and a $185.00 price target for the company. Jefferies Group LLC reissued a “buy” rating and set a $183.00 price target (up from $178.00) on shares of Cigna Corporation in a research note on Friday, May 5th. Finally, Stifel Nicolaus boosted their price target on shares of Cigna Corporation from $170.00 to $175.00 and gave the stock a “buy” rating in a research note on Friday, May 5th. Two equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. Cigna Corporation presently has an average rating of “Buy” and a consensus target price of $176.61.
Cigna Corporation (NYSE:CI) opened at 173.97 on Friday. Cigna Corporation has a one year low of $115.03 and a one year high of $175.80. The company’s 50-day moving average is $170.39 and its 200 day moving average is $157.04. The firm has a market cap of $44.54 billion, a PE ratio of 23.23 and a beta of 0.46.
Cigna Corporation (NYSE:CI) last released its quarterly earnings data on Friday, May 5th. The health services provider reported $2.77 EPS for the quarter, topping the consensus estimate of $2.44 by $0.33. Cigna Corporation had a return on equity of 16.07% and a net margin of 6.53%. The company had revenue of $10.39 billion during the quarter, compared to the consensus estimate of $10.11 billion. During the same period last year, the company earned $2.46 EPS. Cigna Corporation’s revenue for the quarter was up 5.1% on a year-over-year basis. Equities analysts anticipate that Cigna Corporation will post $9.79 earnings per share for the current year.
In related news, CEO David Cordani sold 153,168 shares of Cigna Corporation stock in a transaction dated Monday, June 19th. The stock was sold at an average price of $170.20, for a total value of $26,069,193.60. Following the completion of the sale, the chief executive officer now directly owns 421,162 shares in the company, valued at approximately $71,681,772.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Nicole S. Jones sold 20,312 shares of Cigna Corporation stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $160.04, for a total value of $3,250,732.48. Following the completion of the sale, the executive vice president now owns 44,737 shares of the company’s stock, valued at $7,159,709.48. The disclosure for this sale can be found here. Insiders sold a total of 219,558 shares of company stock valued at $37,135,665 over the last quarter. 1.30% of the stock is owned by corporate insiders.
Cigna Corporation Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.